Results 11 to 20 of about 312,772 (298)

Effect of Subcutaneous Immunotherapy on The Natural Course of Allergic Diseases in Pediatric Patients: A Real-Life Cohort

open access: yesHaseki Tıp Bülteni, 2021
Aim:Specific allergen immunotherapy (SIT) is the only disease-modifying therapy for allergic diseases. We aimed to examine the effect of subcutaneous specific allergen immunotherapy (SCIT) applications on the prognosis of asthma and allergic rhinitis in ...
Ozge Yilmaz   +5 more
doaj   +2 more sources

Safety of subcutaneous immunotherapy with tyrosine-adsorbed house dust mite extracts in patients with allergic disease

open access: yesRevista Alergia México, 2017
Background: In spite of allergen-specific immunotherapy (SIT) multiple benefits, its use is restricted in some countries owing to concerns about severe adverse reactions.
Mónica María Molina-Sáenz   +2 more
doaj   +2 more sources

Subcutaneous Immunotherapy Improves the Symptomatology of Allergic Rhinitis [PDF]

open access: yesInternational Archives of Otorhinolaryngology, 2015
Introduction The relevance of allergic rhinitis is unquestionable. This condition affects people's quality of life and its incidence has increased over the last years. Objective Thus, this study aims to analyze the effectiveness of subcutaneous injectable immunotherapy in cases of nasal itching, sneeze, rhinorrhea and nasal ...
Lourenço, Edmir Américo   +5 more
openaire   +6 more sources

Ascite-solid model of prostate cancer and its morphological characteristics

open access: yesСибирский онкологический журнал, 2023
Targeted therapy and immunotherapy are considered promising novel therapies capable of increasing the effcacy of prostate cancer (PCa) treatment. The purpose of the study was to obtain and characterize TRAMP-C2 subcutaneous and ascite-solid models of ...
E. A. Plotnikova   +7 more
doaj   +1 more source

Clinical Efficacy Evaluation of 1-Year Subcutaneous Immunotherapy for Artemisia sieversiana Pollen Allergic Rhinitis by Serum Metabolomics

open access: yesFrontiers in Pharmacology, 2020
Subcutaneous immunotherapy is the only treatment that improves the natural progression of allergic rhinitis and maintains long-term outcomes after discontinuation of the drug.
Hai-Yun Shi   +11 more
doaj   +1 more source

Electroporation and Immunotherapy—Unleashing the Abscopal Effect

open access: yes, 2022
SIMPLE SUMMARY: Electrochemotherapy and irreversible electroporation are primarily used for treating patients with cutaneous and subcutaneous tumors and pancreatic cancer, respectively.
Nolsoe, Christian   +9 more
core   +1 more source

Subcutaneous versus sublingual immunotherapy [PDF]

open access: yesExpert Review of Clinical Immunology, 2016
The first description of hay fever was by John Bostock in 1819. Since then, allergen IgE sensitization is recognized as playing a major role in allergic rhinoconjunctivitis (ARC), asthma, Hymenopte...
Chen Hsing, Lin   +2 more
openaire   +2 more sources

A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis [PDF]

open access: yes, 2013
© Queen’s Printer and Controller of HMSO 2013Severe allergic rhinitis uncontrolled by conventional medication can substantially affect quality of life. Immunotherapy involves administering increasing doses of a specific allergen, with the aim of reducing
B Kaambwa   +15 more
core   +1 more source

A single centre retrospective study of systemic reactions to subcutaneous immunotherapy

open access: yesAllergy, Asthma & Clinical Immunology, 2020
Background Subcutaneous immunotherapy (SCIT) is the standard approach for treating patients with sensitizations to aeroallergens. However, immunotherapy can trigger severe systemic reactions if delivered inappropriately or to high risk patients.
Kara Robertson   +4 more
doaj   +1 more source

Immunotherapy of lung cancer: An update [PDF]

open access: yes, 2006
In Germany lung cancer is the leading cause of cancer-associated death in men. Surgery, chemotherapy and radiation may enhance survival of patients suffering from lung cancer but the enhancement is typically transient and mostly absent with advanced ...
Hatz, R. A.   +15 more
core   +1 more source

Home - About - Disclaimer - Privacy